We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-11.4%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$57.4B
AUM Growth
-$7.29B
Cap. Flow
+$861M
Cap. Flow %
1.5%
Top 10 Hldgs %
21.3%
Holding
3,843
New
205
Increased
1,398
Reduced
1,819
Closed
309

Sector Composition

Rank Sector Weight
1 Technology 9.78%
2 Financials 8.85%
3 Healthcare 8.68%
4 Industrials 6.29%
5 Consumer Discretionary 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PDT
2976
John Hancock Premium Dividend Fund
PDT
$627M
$241K ﹤0.01%
17,361
-214
-1% -$3.28K
PEZ icon
2977
Invesco Dorsey Wright Consumer Cyclicals Momentum ETF
PEZ
$22.5M
$241K ﹤0.01%
5,167
-6,460
-56% -$334K
RCS
2978
PIMCO Strategic Income Fund
RCS
$249M
$241K ﹤0.01%
24,854
-1,375
-5% -$12.8K
THC icon
2979
Tenet Healthcare
THC
$20.9B
$241K ﹤0.01%
14,084
RSPM icon
2980
Invesco S&P 500 Equal Weight Materials ETF
RSPM
$186M
$240K ﹤0.01%
12,690
-27,915
-69% -$562K
SBI
2981
Western Asset Intermediate Muni Fund
SBI
$107M
$240K ﹤0.01%
28,795
-29,767
-51% -$248K
SPWR
2982
DELISTED
SunPower Corporation Common Stock
SPWR
$240K ﹤0.01%
73,795
+43,121
+141% +$179K
CRZO
2983
DELISTED
Carrizo Oil & Gas Inc
CRZO
$240K ﹤0.01%
21,270
-18,204
-46% -$324K
INDB icon
2984
Independent Bank
INDB
$4.02B
$239K ﹤0.01%
3,394
+245
+8% +$19K
RUSHA icon
2985
Rush Enterprises Class A
RUSHA
$9.52B
$239K ﹤0.01%
15,613
+720
+5% +$11.5K
EQL icon
2986
ALPS Equal Sector Weight ETF
EQL
$764M
$238K ﹤0.01%
11,205
-108
-1% -$2.47K
NVCR icon
2987
NovoCure
NVCR
$2.06B
$238K ﹤0.01%
7,113
+1,714
+32% +$62.7K
MAGN
2988
Magnera Corp
MAGN
$444M
$238K ﹤0.01%
1,874
-82
-4% -$15.7K
ICHR icon
2989
Ichor Holdings
ICHR
$2.53B
$237K ﹤0.01%
14,514
+3,416
+31% +$59K
CCA
2990
DELISTED
MFS California Municipal Fund
CCA
$237K ﹤0.01%
23,655
+10,842
+85% +$108K
NWBI icon
2991
Northwest Bancshares
NWBI
$2.29B
$236K ﹤0.01%
13,959
-3,200
-19% -$54K
TJX icon
2992
CALL
TJX Companies
TJX
$172B
$236K ﹤0.01%
28,800
-60,400
-68% -$3.05M
WMGI
2993
DELISTED
Wright Medical Group Inc
WMGI
$236K ﹤0.01%
+8,664
New +$239K
ACRE
2994
Ares Commercial Real Estate
ACRE
$262M
$235K ﹤0.01%
17,996
-289
-2% -$4.04K
VTWG icon
2995
Vanguard Russell 2000 Growth ETF
VTWG
$1.55B
$235K ﹤0.01%
1,930
+300
+18% +$40.6K
VVV icon
2996
Valvoline
VVV
$4.21B
$235K ﹤0.01%
12,146
-183
-1% -$3.66K
CHGG icon
2997
Chegg
CHGG
$92.8M
$234K ﹤0.01%
+8,226
New +$221K
KRO icon
2998
KRONOS Worldwide
KRO
$963M
$234K ﹤0.01%
20,325
+1,924
+10% +$25.9K
CMD
2999
DELISTED
Cantel Medical Corporation
CMD
$234K ﹤0.01%
3,137
-487
-13% -$40.2K
ALEX
3000
DELISTED
Alexander & Baldwin
ALEX
$233K ﹤0.01%
12,692
-757
-6% -$15.3K

Similar funds

Raymond James & Associates's Q4 2018 Portfolio in Review

As of Q4 2018, Raymond James & Associates held 3,843 positions worth $57.4B, down 11% from $64.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q4 2018 filing shows 205 new, 1,398 increased, 1,819 reduced and 309 closed positions. Its largest new stake was Linde: 549,404 shares worth $87.1M. The largest sale was Oracle, an estimated $124M.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, down from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q4 2018 buy was Linde: 549,404 shares worth $87.1M.
  • Raymond James & Associates added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $368M increase.
  • Raymond James & Associates's biggest Q4 2018 reduction was Oracle, cutting an estimated $124M.
  • Raymond James & Associates fully exited Praxair Inc in Q4 2018, selling an estimated $110M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $57.4B portfolio in Q4 2018.
  • Raymond James & Associates opened 205 new positions and closed 309 in Q4 2018.
  • Raymond James & Associates's portfolio value fell 11% quarter-over-quarter to $57.4B.

Based on Raymond James & Associates's 13F filing for Q4 2018, filed 11 Feb 2019.